Skip to main content

COVID-19 treatments

Find the latest regulatory and safety information on COVID-19 treatments in Australia. 

Last updated

We rigorously assess all COVID-19 treatments for safety, quality and effectiveness before they can be registered for use in Australia.

This page will be regularly updated to keep consumers, health professionals and sponsors informed of the latest regulatory developments.

Latest information on COVID-19 treatments 

More information

Labelling exemptions

Provisional approval

Provisional determination


Report a side effect

The TGA continues to monitor the safety of medicines after they are registered in Australia so that we can detect and respond to any safety concerns. If you think you may be experiencing a significant side effect (also known as an adverse event) to a COVID-19 treatment, you should seek advice from your doctor. Further information about adverse events can be found on the Reporting adverse events web page.

If you think you have experienced a side effect from a COVID-19 treatment you can report it via:

Telephone 1300 134 237 (8am-8pm seven days a week) – the NPS MedicineWise Adverse Medicine Events line
Online form TGA adverse event reporting

Contact us

If you have an enquiry about the COVID-19 treatment regulatory process, use the following contact details:


Telephone 1800 020 653

If you have a general enquiry about COVID-19 or the vaccine roll-out, contact the National Coronavirus Helpline on:

Telephone 1800 020 080 (available 24 hours a day, seven days a week)

Latest news

Help us improve the Therapeutic Goods Administration site